van der Mei, Willem F. http://orcid.org/0000-0002-6396-3790
,
Barbano, Anna C.
Ratanatharathorn, Andrew
Bryant, Richard A.
Delahanty, Douglas L.
deRoon-Cassini, Terri A.
Lai, Betty S.
Lowe, Sarah R.
Matsuoka, Yutaka J.
Olff, Miranda
Qi, Wei
Schnyder, Ulrich
Seedat, Soraya
Kessler, Ronald C.
Koenen, Karestan C.
Shalev, Arieh Y.
Funding for this research was provided by:
National Institute of Mental Health (MH101227)
Article History
Received: 5 June 2019
Accepted: 10 February 2020
First Online: 2 March 2020
Change Date: 29 June 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: ICPP studies included in this work were individually approved by their respective ethics boards, including the Institutional Review Board of Amsterdam Medical Center, Kent State University Institutional Review Board, the Summa Health System Institutional Review Board, and the Committee on Research Involving Human Subjects (Helsinki Committee) of the Hebrew University – Hadassah Medical School.
: Not applicable.
: Dr. Matsuoka reports personal fees from Morinaga Milk, Eli Lilly, and NTT Data. Over the past 3 years, Dr. Kessler received support for his epidemiological studies from Sanofi Aventis; was a consultant for Johnson & Johnson Wellness and Prevention, Sage Pharmaceuticals, Shire, Takeda; and served on an advisory board for the Johnson & Johnson Services Inc. Lake Nona Life Project. Kessler is a co-owner of DataStat, Inc., a market research firm that carries out healthcare research. Other authors report no potential conflict of interest.